Researchers, clinicians, patient advocates, and industry representatives gathered recently at the Broad Institute for the third annual Glom-NExT Symposium (Glom-NExT3), organized by institute member of the Broad, Anna Greka. With the goal of bringing stakeholders together to discuss advancing therapeutics for kidney disease, the symposium featured talks and a roundtable discussion with patient advocates, FDA representation and thought leaders in the field. Due to popular demand, the meeting has been rebranded as Kidney-NExT and will be coming back to Broad next spring.